世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
体外診断サービスの世界市場規模、メーカー、サプライチェーン、販売チャネル、顧客、2022-2028年Global In - Vitro ADME Services Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028 創薬の初期段階では、化合物候補の有効性と安全性プロファイルを駆動する主要な物理化学的特性と構造モチーフを理解することが重要である。In vitro ADMEは、吸収、分布、代謝、および排泄の属性を特定するために... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー創薬の初期段階では、化合物候補の有効性と安全性プロファイルを駆動する主要な物理化学的特性と構造モチーフを理解することが重要である。In vitro ADMEは、吸収、分布、代謝、および排泄の属性を特定するために使用されます。ADMEアッセイは、代謝および潜在的な薬物相互作用に関する洞察を得るために重要である。ハイライト COVID-19およびロシア・ウクライナ戦争の影響による経済変化を考慮すると、体外ADMEサービスの世界市場は、2023年から2028年の間に8.9%のCAGRで、2022年の推定8億7330万米ドルから2028年までに1億4560万米ドルに達すると予測されます。 世界の体外ADMEサービス企業には、チャールズリバー、Labcorp、Envigo、Curia、Evotecなどがあります。世界の上位3社で32%以上のシェアを占めています。北米が約47%のシェアで最大市場であり、欧州、アジア太平洋地域がそれに続く。 レポート範囲 本レポートは、体外診断用医薬品サービスの世界市場について、定量的および定性的な分析を交えて包括的に紹介し、読者が事業/成長戦略の策定、市場競争状況の評価、現在の市場における自社のポジション分析、および体外診断用医薬品サービスに関する十分なビジネス判断を下せるようにすることを目的としたものです。 体外ADMEサービスの市場規模、推計、予測は、2021年を基準年とし、2017年から2028年までの歴史と予測データを考慮し、収益（百万ドル）の単位で提供します。本レポートでは、世界の体外ADMEサービス市場を包括的に区分しています。また、タイプ別、エンドユーザー別、プレイヤー別の製品に関する地域別市場規模も掲載しています。市場規模を推計する際には、COVID-19やロシア・ウクライナ戦争の影響も考慮しました。 市場をより深く理解するために、競合環境、主要な競合他社、それぞれの市場順位などのプロフィールを掲載しています。また、技術動向や新製品開発についても考察しています。 当レポートは、この市場における体外ADMEサービス企業、新規参入企業、産業チェーン関連企業に対し、市場全体および企業別、製品タイプ別、エンドユーザー別、地域別のサブセグメントにおける収益に関する情報を提供するものである。 主要企業および市場シェアの洞察 本セクションでは、読者は競合する主要企業について理解を深めることができます。本レポートでは、革新的なトレンドと開発、製品ポートフォリオの強化、M&A、コラボレーション、新製品イノベーション、地域的拡大など、これらの参加企業がプレゼンスを維持するために行った主要な成長戦略を調査しています。事業戦略とは別に、本調査には現在の開発状況や主要財務情報も含まれています。読者はまた、期間2017-2022の企業による世界収益に関連するデータへのアクセスを取得します。この包括的なレポートは、確かに更新を維持し、彼らのビジネスで効果的な意思決定を行うためにクライアントに役立つだろう。調査レポートでレビューされている著名なプレイヤーには、以下のようなものがあります。 チャールズリバー ラボコープ エンビゴ キュリア エボテック ビオデュロ・スンディア ロンザ WuXi AppTec IQVIA テカン・グループ ファーマロン 上海メディシロン ケムパートナー ジョインラボラトリーズ RTIインターナショナル ユーロフィンズサイエンティフィック アラゲンライフサイエンス サイ・ライフ・サイエンス 製品タイプ別インサイト 世界市場を体外ADMEサービスのタイプ別に、2028年までの成長予測とともに紹介します。収益の見積もりは、体外ADMEサービスが企業によって調達されるサプライチェーンにおける価格に基づいています。 本レポートでは、各セグメントを調査し、過去のデータを用いて市場規模を提示しています。また、将来的にセグメントがもたらす可能性のある成長機会についても触れています。この研究は、タイプ別、および歴史的期間（2017-2022）と予測期間（2023-2028）の収益データを授けるものである。 体外ADMEサービス タイプ別セグメント 低分子化合物 バイオロジクス アプリケーションインサイト 本レポートでは、過去期間（2017-2022年）および予測期間（2023-2028年）におけるエンドユーザー別の市場規模（収益データ）を掲載しています。 また、体外ADMEサービス市場に影響を与える各分野の市場動向や消費者行動、これらが業界の将来にどのような影響を与えるかについて概説しています。本レポートは、体外診断用医薬品（In - Vitro ADME Services）市場を牽引する関連市場および消費者動向の把握にお役立ていただけます。 体外ADMEサービスのエンドユーザー別セグメント バイオ製薬会社 政府機関および学術機関 その他 地域別展望 本セクションでは、様々な地域と各地域で活動する主要企業に関する主要な洞察を提供します。特定の地域/国の成長を評価する際に、経済的、社会的、環境的、技術的、政治的な要因が考慮されています。読者はまた、2017年から2028年までの各地域および国の収益に手を触れることになります。 市場は、北米、ヨーロッパ、アジア太平洋、南米、中東＆アフリカなど、様々な主要地域に区分されています。アメリカ、ドイツ、イギリス、イタリア、フランス、中国、日本、韓国、東南アジア、インドなどの主要国の詳細な分析は、地域セグメント内でカバーされる予定です。市場推定については、2021年を基準年としてデータを提供し、2022年の推定値と2028年の予測収益を提供する予定である。 北米 米国 カナダ 欧州 ドイツ フランス 英国 イタリア ロシア 北欧諸国 ベネルクス その他の欧州地域 アジア太平洋地域 中国 日本 韓国 インド 東南アジア オーストラリア その他のアジア太平洋地域 中南米 メキシコ ブラジル アルゼンチン ラテンアメリカのその他 中近東・アフリカ トルコ サウジアラビア UAE その他の中東・アフリカ 主要なドライバーと障壁 本レポートでは、読者が一般的な開発を理解するのに役立つように、影響の大きいレンダリング要因とドライバーを調査しています。さらに、このレポートには、プレイヤーの道を阻むブロックとして機能する可能性のある抑制と課題も含まれています。これは、ユーザーが気を配り、ビジネスに関連する情報に基づいた意思決定を行うために支援します。専門家はまた、今後のビジネスの展望に彼らの焦点を置いています。 COVID-19とロシア・ウクライナ戦争影響力分析 このセクションの読者は、パンデミック、ポストパンデミック、ロシア・ウクライナ戦争中に体外ADMEサービス市場のシナリオが世界中でどのように変化したかを理解することができます。この研究は、需要、消費、輸送、消費者行動、サプライチェーン管理などの側面の変化を視野に入れながら行われます。また、業界の専門家は、今後数年間でプレイヤーに機会を創出し、業界全体を安定させるのに役立つ主要因を強調しています。 本レポートを購入する理由 本レポートは、読者が潜在的な利益を高めるために、産業内の競争と競争環境に対する戦略を理解するのに役立ちます。また、世界の体外ADMEサービス市場の競争環境に焦点を当て、主要企業の市場シェア、産業ランキング、競合他社のエコシステム、市場実績、新製品開発、経営状況、拡張、買収などを詳細に紹介し、読者が主要競合企業を特定し、市場の競争パターンを深く理解できるよう支援します。 本レポートは、関係者が体外ADMEサービスの世界的な産業状況と動向を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。 本レポートは、利害関係者が競合他社をより良く理解し、ビジネスにおける自社の地位を強化するためのより多くの洞察を得るのに役立ちます。競争環境のセクションでは、市場シェアと順位（金額）、競合のエコシステム、新製品開発、拡大、買収を含みます。 本レポートは、新規技術の統合、機能、市場の最新動向を常にアップデートしています。 本レポートは、関係者がCOVID-19とロシア・ウクライナ戦争が体外ADMEサービス産業に及ぼす影響を理解するのに役立ちます。 本レポートは、関係者が世界的にどの地域をターゲットとすべきなのかについての洞察を得るのに役立ちます。 本レポートは、体外ADMEサービスの採用に関するエンドユーザーの認識について利害関係者が洞察することを支援します。 本レポートは、利害関係者が市場の主要プレイヤーを特定し、その貴重な貢献度を理解するのに役立ちます。 目次1 Study Coverage1.1 In - Vitro ADME Services Product Introduction 1.2 Market by Type 1.2.1 Global In - Vitro ADME Services Market Size Growth Rate by Type (2017 VS 2021 VS 2028) 1.2.2 Small Molecules 1.2.3 Biologics 1.3 Market by End User 1.3.1 Global In - Vitro ADME Services Market Size Growth Rate by End User (2017 VS 2021 VS 2028) 1.3.2 Biopharmaceutical Companies 1.3.3 Government and Academic Institutes 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global In - Vitro ADME Services Market Size Estimates and Forecasts 2.2 In - Vitro ADME Services Market Size by Region: 2022 Versus 2028 2.2.1 Global In - Vitro ADME Services Revenue by Region: 2017-2022 2.2.2 Global In - Vitro ADME Services Revenue Forecast by Region (2023-2028) 2.2.3 Global In - Vitro ADME Services Revenue Market Share by Region (2017-2028) 3 Global In - Vitro ADME Services by Company 3.1 Global In - Vitro ADME Services Revenue by Company (2017-2022) 3.2 Global In - Vitro ADME Services Revenue Share by Company (2017-2022) 3.3 Competitive Landscape 3.3.1 Key In - Vitro ADME Services Companies around the World: Ranking by Revenue 3.3.2 Global In - Vitro ADME Services Market Concentration Ratio (CR5 and HHI) & (2017-2022) 3.3.3 Global In - Vitro ADME Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.4 Global In - Vitro ADME Services Companies Headquarters & Product Type 3.4.1 In - Vitro ADME Services Companies Headquarters 3.4.2 Global In - Vitro ADME Services Companies Product & Service 3.4.3 Date of International Companies Enter into In - Vitro ADME Services Market 3.5 Global In - Vitro ADME Services Mergers & Acquisitions, Expansion Plans 4 Company Profiles 4.1 Charles River 4.1.1 Charles River Corporation Information 4.1.2 Charles River Description, Business Overview 4.1.3 Charles River In - Vitro ADME Services Products Offered 4.1.4 Charles River In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.1.5 Charles River In - Vitro ADME Services Revenue by Product in 2021 4.1.6 Charles River In - Vitro ADME Services Revenue by End User in 2021 4.1.7 Charles River In - Vitro ADME Services Revenue by Geographic Area in 2021 4.1.8 Charles River Recent Developments 4.2 Labcorp 4.2.1 Labcorp Corporation Information 4.2.2 Labcorp Description, Business Overview 4.2.3 Labcorp In - Vitro ADME Services Products Offered 4.2.4 Labcorp In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.2.5 Labcorp In - Vitro ADME Services Revenue by Product in 2021 4.2.6 Labcorp In - Vitro ADME Services Revenue by End User in 2021 4.2.7 Labcorp In - Vitro ADME Services Revenue by Geographic Area in 2021 4.2.8 Labcorp Recent Developments 4.3 Envigo 4.3.1 Envigo Corporation Information 4.3.2 Envigo Description, Business Overview 4.3.3 Envigo In - Vitro ADME Services Products Offered 4.3.4 Envigo In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.3.5 Envigo In - Vitro ADME Services Revenue by Product in 2021 4.3.6 Envigo In - Vitro ADME Services Revenue by End User in 2021 4.3.7 Envigo In - Vitro ADME Services Revenue by Geographic Area in 2021 4.3.8 Envigo Recent Developments 4.4 Curia 4.4.1 Curia Corporation Information 4.4.2 Curia Description, Business Overview 4.4.3 Curia In - Vitro ADME Services Products Offered 4.4.4 Curia In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.4.5 Curia In - Vitro ADME Services Revenue by Product in 2021 4.4.6 Curia In - Vitro ADME Services Revenue by End User in 2021 4.4.7 Curia In - Vitro ADME Services Revenue by Geographic Area in 2021 4.4.8 Curia Recent Developments 4.5 Evotec 4.5.1 Evotec Corporation Information 4.5.2 Evotec Description, Business Overview 4.5.3 Evotec In - Vitro ADME Services Products Offered 4.5.4 Evotec In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.5.5 Evotec In - Vitro ADME Services Revenue by Product in 2021 4.5.6 Evotec In - Vitro ADME Services Revenue by End User in 2021 4.5.7 Evotec In - Vitro ADME Services Revenue by Geographic Area in 2021 4.5.8 Evotec Recent Developments 4.6 Bioduro-Sundia 4.6.1 Bioduro-Sundia Corporation Information 4.6.2 Bioduro-Sundia Description, Business Overview 4.6.3 Bioduro-Sundia In - Vitro ADME Services Products Offered 4.6.4 Bioduro-Sundia In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.6.5 Bioduro-Sundia In - Vitro ADME Services Revenue by Product in 2021 4.6.6 Bioduro-Sundia In - Vitro ADME Services Revenue by End User in 2021 4.6.7 Bioduro-Sundia In - Vitro ADME Services Revenue by Geographic Area in 2021 4.6.8 Bioduro-Sundia Recent Development 4.7 Lonza 4.7.1 Lonza Corporation Information 4.7.2 Lonza Description, Business Overview 4.7.3 Lonza In - Vitro ADME Services Products Offered 4.7.4 Lonza In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.7.5 Lonza In - Vitro ADME Services Revenue by Product in 2021 4.7.6 Lonza In - Vitro ADME Services Revenue by End User in 2021 4.7.7 Lonza In - Vitro ADME Services Revenue by Geographic Area in 2021 4.7.8 Lonza Recent Development 4.8 WuXi AppTec 4.8.1 WuXi AppTec Corporation Information 4.8.2 WuXi AppTec Description, Business Overview 4.8.3 WuXi AppTec In - Vitro ADME Services Products Offered 4.8.4 WuXi AppTec In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.8.5 WuXi AppTec In - Vitro ADME Services Revenue by Product in 2021 4.8.6 WuXi AppTec In - Vitro ADME Services Revenue by End User in 2021 4.8.7 WuXi AppTec In - Vitro ADME Services Revenue by Geographic Area in 2021 4.8.8 WuXi AppTec Recent Development 4.9 IQVIA 4.9.1 IQVIA Corporation Information 4.9.2 IQVIA Description, Business Overview 4.9.3 IQVIA In - Vitro ADME Services Products Offered 4.9.4 IQVIA In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.9.5 IQVIA In - Vitro ADME Services Revenue by Product in 2021 4.9.6 IQVIA In - Vitro ADME Services Revenue by End User in 2021 4.9.7 IQVIA In - Vitro ADME Services Revenue by Geographic Area in 2021 4.9.8 IQVIA Recent Development 4.10 Tecan Group 4.10.1 Tecan Group Corporation Information 4.10.2 Tecan Group Description, Business Overview 4.10.3 Tecan Group In - Vitro ADME Services Products Offered 4.10.4 Tecan Group In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.10.5 Tecan Group In - Vitro ADME Services Revenue by Product in 2021 4.10.6 Tecan Group In - Vitro ADME Services Revenue by End User in 2021 4.10.7 Tecan Group In - Vitro ADME Services Revenue by Geographic Area in 2021 4.10.8 Tecan Group Recent Development 4.11 Pharmaron 4.11.1 Pharmaron Corporation Information 4.11.2 Pharmaron Description, Business Overview 4.11.3 Pharmaron In - Vitro ADME Services Products Offered 4.11.4 Pharmaron In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.11.5 Pharmaron In - Vitro ADME Services Revenue by Product in 2021 4.11.6 Pharmaron In - Vitro ADME Services Revenue by End User in 2021 4.11.7 Pharmaron In - Vitro ADME Services Revenue by Geographic Area in 2021 4.11.8 Pharmaron Recent Development 4.12 Shanghai Medicilon 4.12.1 Shanghai Medicilon Corporation Information 4.12.2 Shanghai Medicilon Description, Business Overview 4.12.3 Shanghai Medicilon In - Vitro ADME Services Products Offered 4.12.4 Shanghai Medicilon In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.12.5 Shanghai Medicilon In - Vitro ADME Services Revenue by Product in 2021 4.12.6 Shanghai Medicilon In - Vitro ADME Services Revenue by End User in 2021 4.12.7 Shanghai Medicilon In - Vitro ADME Services Revenue by Geographic Area in 2021 4.12.8 Shanghai Medicilon Recent Development 4.13 ChemPartner 4.13.1 ChemPartner Corporation Information 4.13.2 ChemPartner Description, Business Overview 4.13.3 ChemPartner In - Vitro ADME Services Products Offered 4.13.4 ChemPartner In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.13.5 ChemPartner In - Vitro ADME Services Revenue by Product in 2021 4.13.6 ChemPartner In - Vitro ADME Services Revenue by End User in 2021 4.13.7 ChemPartner In - Vitro ADME Services Revenue by Geographic Area in 2021 4.13.8 ChemPartner Recent Development 4.14 Joinn Laboratories 4.14.1 Joinn Laboratories Corporation Information 4.14.2 Joinn Laboratories Description, Business Overview 4.14.3 Joinn Laboratories In - Vitro ADME Services Products Offered 4.14.4 Joinn Laboratories In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.14.5 Joinn Laboratories In - Vitro ADME Services Revenue by Product in 2021 4.14.6 Joinn Laboratories In - Vitro ADME Services Revenue by End User in 2021 4.14.7 Joinn Laboratories In - Vitro ADME Services Revenue by Geographic Area in 2021 4.14.8 Joinn Laboratories Recent Development 4.15 RTI International 4.15.1 RTI International Corporation Information 4.15.2 RTI International Description, Business Overview 4.15.3 RTI International In - Vitro ADME Services Products Offered 4.15.4 RTI International In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.15.5 RTI International In - Vitro ADME Services Revenue by Product in 2021 4.15.6 RTI International In - Vitro ADME Services Revenue by End User in 2021 4.15.7 RTI International In - Vitro ADME Services Revenue by Geographic Area in 2021 4.15.8 RTI International Recent Development 4.16 Eurofins Scientific 4.16.1 Eurofins Scientific Corporation Information 4.16.2 Eurofins Scientific Description, Business Overview 4.16.3 Eurofins Scientific In - Vitro ADME Services Products Offered 4.16.4 Eurofins Scientific In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.16.5 Eurofins Scientific In - Vitro ADME Services Revenue by Product in 2021 4.16.6 Eurofins Scientific In - Vitro ADME Services Revenue by End User in 2021 4.16.7 Eurofins Scientific In - Vitro ADME Services Revenue by Geographic Area in 2021 4.16.8 Eurofins Scientific Recent Development 4.17 Aragen Life Sciences 4.17.1 Aragen Life Sciences Corporation Information 4.17.2 Aragen Life Sciences Description, Business Overview 4.17.3 Aragen Life Sciences In - Vitro ADME Services Products Offered 4.17.4 Aragen Life Sciences In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.17.5 Aragen Life Sciences In - Vitro ADME Services Revenue by Product in 2021 4.17.6 Aragen Life Sciences In - Vitro ADME Services Revenue by End User in 2021 4.17.7 Aragen Life Sciences In - Vitro ADME Services Revenue by Geographic Area in 2021 4.17.8 Aragen Life Sciences Recent Development 4.18 Sai Life Sciences 4.18.1 Sai Life Sciences Corporation Information 4.18.2 Sai Life Sciences Description, Business Overview 4.18.3 Sai Life Sciences In - Vitro ADME Services Products Offered 4.18.4 Sai Life Sciences In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.18.5 Sai Life Sciences In - Vitro ADME Services Revenue by Product in 2021 4.18.6 Sai Life Sciences In - Vitro ADME Services Revenue by End User in 2021 4.18.7 Sai Life Sciences In - Vitro ADME Services Revenue by Geographic Area in 2021 4.18.8 Sai Life Sciences Recent Development 5 Breakdown Data by Type 5.1 Global In - Vitro ADME Services Revenue by Type (2017-2022) 5.2 Global In - Vitro ADME Services Revenue Forecast by Type (2023-2028) 5.3 In - Vitro ADME Services Revenue Marke Share by Type (2017-2028) 6 Breakdown Data by End User 6.1 Global In - Vitro ADME Services Revenue by End User (2017-2022) 6.2 Global In - Vitro ADME Services Revenue Forecast by End User (2023-2028) 6.3 In - Vitro ADME Services Revenue Market Share by End User (2017-2028) 7 North America 7.1 North America In - Vitro ADME Services Market Size YoY Growth 2017-2028 7.2 North America In - Vitro ADME Services Market Facts & Figures by Country (2017-2028) 7.3 North America In - Vitro ADME Services Revenue by Type (2017-2022) 7.4 North America In - Vitro ADME Services Revenue by End User (2017-2022) 8 Asia-Pacific 8.1 Asia-Pacific In - Vitro ADME Services Market Size YoY Growth 2017-2028 8.2 Asia-Pacific In - Vitro ADME Services Market Facts & Figures by Region (2017-2028) 8.3 Asia-Pacific In - Vitro ADME Services Revenue by Type (2017-2022) 8.4 Asia-Pacific In - Vitro ADME Services Revenue by End User (2017-2022) 9 Europe 9.1 Europe In - Vitro ADME Services Market Size YoY Growth 2017-2028 9.2 Europe In - Vitro ADME Services Market Facts & Figures by Country (2017-2028) 9.3 Europe In - Vitro ADME Services Revenue by Type (2017-2022) 9.4 Europe In - Vitro ADME Services Revenue by End User (2017-2022) 10 Latin America 10.1 Latin America In - Vitro ADME Services Market Size YoY Growth 2017-2028 10.2 Latin America In - Vitro ADME Services Market Facts & Figures by Country (2017-2028) 10.3 Latin America In - Vitro ADME Services Revenue by Type (2017-2022) 10.4 Latin America In - Vitro ADME Services Revenue by End User (2017-2022) 11 Middle East and Africa 11.1 Middle East and Africa In - Vitro ADME Services Market Size YoY Growth 2017-2028 11.2 Middle East and Africa In - Vitro ADME Services Market Facts & Figures by Country (2017-2028) 11.3 Middle East and Africa In - Vitro ADME Services Revenue by Type (2017-2022) 11.4 Middle East and Africa In - Vitro ADME Services Revenue by End User (2017-2022) 12 Supply Chain and Sales Channel Analysis 12.1 In - Vitro ADME Services Supply Chain Analysis 12.2 In - Vitro ADME Services Key Raw Materials and Upstream Suppliers 12.3 In - Vitro ADME Services Clients Analysis 12.4 In - Vitro ADME Services Sales Channel and Sales Model Analysis 12.4.1 In - Vitro ADME Services Distribution Channel Analysis: Indirect Sales VS Direct Sales 12.4.2 In - Vitro ADME Services Distribution Channel Analysis: Online Sales VS Offline Sales 12.4.3 In - Vitro ADME Services Distributors 13 Market Dynamics 13.1 In - Vitro ADME Services Industry Trends 13.2 In - Vitro ADME Services Market Drivers 13.3 In - Vitro ADME Services Market Challenges 13.4 In - Vitro ADME Services Market Restraints 14 Research Findings and Conclusion 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
SummaryIn the early stages of drug discovery, it is important to understand the key physicochemical properties and structural motifs that drive the efficacy and safety profile of a compound candidate. In vitro ADME is used to identify the attributes of absorption, distribution, metabolism, and excretion. ADME assays are critical in gaining insight into metabolism and potential drug interactions. Table of Contents1 Study Coverage1.1 In - Vitro ADME Services Product Introduction 1.2 Market by Type 1.2.1 Global In - Vitro ADME Services Market Size Growth Rate by Type (2017 VS 2021 VS 2028) 1.2.2 Small Molecules 1.2.3 Biologics 1.3 Market by End User 1.3.1 Global In - Vitro ADME Services Market Size Growth Rate by End User (2017 VS 2021 VS 2028) 1.3.2 Biopharmaceutical Companies 1.3.3 Government and Academic Institutes 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global In - Vitro ADME Services Market Size Estimates and Forecasts 2.2 In - Vitro ADME Services Market Size by Region: 2022 Versus 2028 2.2.1 Global In - Vitro ADME Services Revenue by Region: 2017-2022 2.2.2 Global In - Vitro ADME Services Revenue Forecast by Region (2023-2028) 2.2.3 Global In - Vitro ADME Services Revenue Market Share by Region (2017-2028) 3 Global In - Vitro ADME Services by Company 3.1 Global In - Vitro ADME Services Revenue by Company (2017-2022) 3.2 Global In - Vitro ADME Services Revenue Share by Company (2017-2022) 3.3 Competitive Landscape 3.3.1 Key In - Vitro ADME Services Companies around the World: Ranking by Revenue 3.3.2 Global In - Vitro ADME Services Market Concentration Ratio (CR5 and HHI) & (2017-2022) 3.3.3 Global In - Vitro ADME Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.4 Global In - Vitro ADME Services Companies Headquarters & Product Type 3.4.1 In - Vitro ADME Services Companies Headquarters 3.4.2 Global In - Vitro ADME Services Companies Product & Service 3.4.3 Date of International Companies Enter into In - Vitro ADME Services Market 3.5 Global In - Vitro ADME Services Mergers & Acquisitions, Expansion Plans 4 Company Profiles 4.1 Charles River 4.1.1 Charles River Corporation Information 4.1.2 Charles River Description, Business Overview 4.1.3 Charles River In - Vitro ADME Services Products Offered 4.1.4 Charles River In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.1.5 Charles River In - Vitro ADME Services Revenue by Product in 2021 4.1.6 Charles River In - Vitro ADME Services Revenue by End User in 2021 4.1.7 Charles River In - Vitro ADME Services Revenue by Geographic Area in 2021 4.1.8 Charles River Recent Developments 4.2 Labcorp 4.2.1 Labcorp Corporation Information 4.2.2 Labcorp Description, Business Overview 4.2.3 Labcorp In - Vitro ADME Services Products Offered 4.2.4 Labcorp In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.2.5 Labcorp In - Vitro ADME Services Revenue by Product in 2021 4.2.6 Labcorp In - Vitro ADME Services Revenue by End User in 2021 4.2.7 Labcorp In - Vitro ADME Services Revenue by Geographic Area in 2021 4.2.8 Labcorp Recent Developments 4.3 Envigo 4.3.1 Envigo Corporation Information 4.3.2 Envigo Description, Business Overview 4.3.3 Envigo In - Vitro ADME Services Products Offered 4.3.4 Envigo In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.3.5 Envigo In - Vitro ADME Services Revenue by Product in 2021 4.3.6 Envigo In - Vitro ADME Services Revenue by End User in 2021 4.3.7 Envigo In - Vitro ADME Services Revenue by Geographic Area in 2021 4.3.8 Envigo Recent Developments 4.4 Curia 4.4.1 Curia Corporation Information 4.4.2 Curia Description, Business Overview 4.4.3 Curia In - Vitro ADME Services Products Offered 4.4.4 Curia In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.4.5 Curia In - Vitro ADME Services Revenue by Product in 2021 4.4.6 Curia In - Vitro ADME Services Revenue by End User in 2021 4.4.7 Curia In - Vitro ADME Services Revenue by Geographic Area in 2021 4.4.8 Curia Recent Developments 4.5 Evotec 4.5.1 Evotec Corporation Information 4.5.2 Evotec Description, Business Overview 4.5.3 Evotec In - Vitro ADME Services Products Offered 4.5.4 Evotec In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.5.5 Evotec In - Vitro ADME Services Revenue by Product in 2021 4.5.6 Evotec In - Vitro ADME Services Revenue by End User in 2021 4.5.7 Evotec In - Vitro ADME Services Revenue by Geographic Area in 2021 4.5.8 Evotec Recent Developments 4.6 Bioduro-Sundia 4.6.1 Bioduro-Sundia Corporation Information 4.6.2 Bioduro-Sundia Description, Business Overview 4.6.3 Bioduro-Sundia In - Vitro ADME Services Products Offered 4.6.4 Bioduro-Sundia In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.6.5 Bioduro-Sundia In - Vitro ADME Services Revenue by Product in 2021 4.6.6 Bioduro-Sundia In - Vitro ADME Services Revenue by End User in 2021 4.6.7 Bioduro-Sundia In - Vitro ADME Services Revenue by Geographic Area in 2021 4.6.8 Bioduro-Sundia Recent Development 4.7 Lonza 4.7.1 Lonza Corporation Information 4.7.2 Lonza Description, Business Overview 4.7.3 Lonza In - Vitro ADME Services Products Offered 4.7.4 Lonza In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.7.5 Lonza In - Vitro ADME Services Revenue by Product in 2021 4.7.6 Lonza In - Vitro ADME Services Revenue by End User in 2021 4.7.7 Lonza In - Vitro ADME Services Revenue by Geographic Area in 2021 4.7.8 Lonza Recent Development 4.8 WuXi AppTec 4.8.1 WuXi AppTec Corporation Information 4.8.2 WuXi AppTec Description, Business Overview 4.8.3 WuXi AppTec In - Vitro ADME Services Products Offered 4.8.4 WuXi AppTec In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.8.5 WuXi AppTec In - Vitro ADME Services Revenue by Product in 2021 4.8.6 WuXi AppTec In - Vitro ADME Services Revenue by End User in 2021 4.8.7 WuXi AppTec In - Vitro ADME Services Revenue by Geographic Area in 2021 4.8.8 WuXi AppTec Recent Development 4.9 IQVIA 4.9.1 IQVIA Corporation Information 4.9.2 IQVIA Description, Business Overview 4.9.3 IQVIA In - Vitro ADME Services Products Offered 4.9.4 IQVIA In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.9.5 IQVIA In - Vitro ADME Services Revenue by Product in 2021 4.9.6 IQVIA In - Vitro ADME Services Revenue by End User in 2021 4.9.7 IQVIA In - Vitro ADME Services Revenue by Geographic Area in 2021 4.9.8 IQVIA Recent Development 4.10 Tecan Group 4.10.1 Tecan Group Corporation Information 4.10.2 Tecan Group Description, Business Overview 4.10.3 Tecan Group In - Vitro ADME Services Products Offered 4.10.4 Tecan Group In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.10.5 Tecan Group In - Vitro ADME Services Revenue by Product in 2021 4.10.6 Tecan Group In - Vitro ADME Services Revenue by End User in 2021 4.10.7 Tecan Group In - Vitro ADME Services Revenue by Geographic Area in 2021 4.10.8 Tecan Group Recent Development 4.11 Pharmaron 4.11.1 Pharmaron Corporation Information 4.11.2 Pharmaron Description, Business Overview 4.11.3 Pharmaron In - Vitro ADME Services Products Offered 4.11.4 Pharmaron In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.11.5 Pharmaron In - Vitro ADME Services Revenue by Product in 2021 4.11.6 Pharmaron In - Vitro ADME Services Revenue by End User in 2021 4.11.7 Pharmaron In - Vitro ADME Services Revenue by Geographic Area in 2021 4.11.8 Pharmaron Recent Development 4.12 Shanghai Medicilon 4.12.1 Shanghai Medicilon Corporation Information 4.12.2 Shanghai Medicilon Description, Business Overview 4.12.3 Shanghai Medicilon In - Vitro ADME Services Products Offered 4.12.4 Shanghai Medicilon In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.12.5 Shanghai Medicilon In - Vitro ADME Services Revenue by Product in 2021 4.12.6 Shanghai Medicilon In - Vitro ADME Services Revenue by End User in 2021 4.12.7 Shanghai Medicilon In - Vitro ADME Services Revenue by Geographic Area in 2021 4.12.8 Shanghai Medicilon Recent Development 4.13 ChemPartner 4.13.1 ChemPartner Corporation Information 4.13.2 ChemPartner Description, Business Overview 4.13.3 ChemPartner In - Vitro ADME Services Products Offered 4.13.4 ChemPartner In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.13.5 ChemPartner In - Vitro ADME Services Revenue by Product in 2021 4.13.6 ChemPartner In - Vitro ADME Services Revenue by End User in 2021 4.13.7 ChemPartner In - Vitro ADME Services Revenue by Geographic Area in 2021 4.13.8 ChemPartner Recent Development 4.14 Joinn Laboratories 4.14.1 Joinn Laboratories Corporation Information 4.14.2 Joinn Laboratories Description, Business Overview 4.14.3 Joinn Laboratories In - Vitro ADME Services Products Offered 4.14.4 Joinn Laboratories In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.14.5 Joinn Laboratories In - Vitro ADME Services Revenue by Product in 2021 4.14.6 Joinn Laboratories In - Vitro ADME Services Revenue by End User in 2021 4.14.7 Joinn Laboratories In - Vitro ADME Services Revenue by Geographic Area in 2021 4.14.8 Joinn Laboratories Recent Development 4.15 RTI International 4.15.1 RTI International Corporation Information 4.15.2 RTI International Description, Business Overview 4.15.3 RTI International In - Vitro ADME Services Products Offered 4.15.4 RTI International In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.15.5 RTI International In - Vitro ADME Services Revenue by Product in 2021 4.15.6 RTI International In - Vitro ADME Services Revenue by End User in 2021 4.15.7 RTI International In - Vitro ADME Services Revenue by Geographic Area in 2021 4.15.8 RTI International Recent Development 4.16 Eurofins Scientific 4.16.1 Eurofins Scientific Corporation Information 4.16.2 Eurofins Scientific Description, Business Overview 4.16.3 Eurofins Scientific In - Vitro ADME Services Products Offered 4.16.4 Eurofins Scientific In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.16.5 Eurofins Scientific In - Vitro ADME Services Revenue by Product in 2021 4.16.6 Eurofins Scientific In - Vitro ADME Services Revenue by End User in 2021 4.16.7 Eurofins Scientific In - Vitro ADME Services Revenue by Geographic Area in 2021 4.16.8 Eurofins Scientific Recent Development 4.17 Aragen Life Sciences 4.17.1 Aragen Life Sciences Corporation Information 4.17.2 Aragen Life Sciences Description, Business Overview 4.17.3 Aragen Life Sciences In - Vitro ADME Services Products Offered 4.17.4 Aragen Life Sciences In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.17.5 Aragen Life Sciences In - Vitro ADME Services Revenue by Product in 2021 4.17.6 Aragen Life Sciences In - Vitro ADME Services Revenue by End User in 2021 4.17.7 Aragen Life Sciences In - Vitro ADME Services Revenue by Geographic Area in 2021 4.17.8 Aragen Life Sciences Recent Development 4.18 Sai Life Sciences 4.18.1 Sai Life Sciences Corporation Information 4.18.2 Sai Life Sciences Description, Business Overview 4.18.3 Sai Life Sciences In - Vitro ADME Services Products Offered 4.18.4 Sai Life Sciences In - Vitro ADME Services Revenue and Gross Margin (2017-2022) 4.18.5 Sai Life Sciences In - Vitro ADME Services Revenue by Product in 2021 4.18.6 Sai Life Sciences In - Vitro ADME Services Revenue by End User in 2021 4.18.7 Sai Life Sciences In - Vitro ADME Services Revenue by Geographic Area in 2021 4.18.8 Sai Life Sciences Recent Development 5 Breakdown Data by Type 5.1 Global In - Vitro ADME Services Revenue by Type (2017-2022) 5.2 Global In - Vitro ADME Services Revenue Forecast by Type (2023-2028) 5.3 In - Vitro ADME Services Revenue Marke Share by Type (2017-2028) 6 Breakdown Data by End User 6.1 Global In - Vitro ADME Services Revenue by End User (2017-2022) 6.2 Global In - Vitro ADME Services Revenue Forecast by End User (2023-2028) 6.3 In - Vitro ADME Services Revenue Market Share by End User (2017-2028) 7 North America 7.1 North America In - Vitro ADME Services Market Size YoY Growth 2017-2028 7.2 North America In - Vitro ADME Services Market Facts & Figures by Country (2017-2028) 7.3 North America In - Vitro ADME Services Revenue by Type (2017-2022) 7.4 North America In - Vitro ADME Services Revenue by End User (2017-2022) 8 Asia-Pacific 8.1 Asia-Pacific In - Vitro ADME Services Market Size YoY Growth 2017-2028 8.2 Asia-Pacific In - Vitro ADME Services Market Facts & Figures by Region (2017-2028) 8.3 Asia-Pacific In - Vitro ADME Services Revenue by Type (2017-2022) 8.4 Asia-Pacific In - Vitro ADME Services Revenue by End User (2017-2022) 9 Europe 9.1 Europe In - Vitro ADME Services Market Size YoY Growth 2017-2028 9.2 Europe In - Vitro ADME Services Market Facts & Figures by Country (2017-2028) 9.3 Europe In - Vitro ADME Services Revenue by Type (2017-2022) 9.4 Europe In - Vitro ADME Services Revenue by End User (2017-2022) 10 Latin America 10.1 Latin America In - Vitro ADME Services Market Size YoY Growth 2017-2028 10.2 Latin America In - Vitro ADME Services Market Facts & Figures by Country (2017-2028) 10.3 Latin America In - Vitro ADME Services Revenue by Type (2017-2022) 10.4 Latin America In - Vitro ADME Services Revenue by End User (2017-2022) 11 Middle East and Africa 11.1 Middle East and Africa In - Vitro ADME Services Market Size YoY Growth 2017-2028 11.2 Middle East and Africa In - Vitro ADME Services Market Facts & Figures by Country (2017-2028) 11.3 Middle East and Africa In - Vitro ADME Services Revenue by Type (2017-2022) 11.4 Middle East and Africa In - Vitro ADME Services Revenue by End User (2017-2022) 12 Supply Chain and Sales Channel Analysis 12.1 In - Vitro ADME Services Supply Chain Analysis 12.2 In - Vitro ADME Services Key Raw Materials and Upstream Suppliers 12.3 In - Vitro ADME Services Clients Analysis 12.4 In - Vitro ADME Services Sales Channel and Sales Model Analysis 12.4.1 In - Vitro ADME Services Distribution Channel Analysis: Indirect Sales VS Direct Sales 12.4.2 In - Vitro ADME Services Distribution Channel Analysis: Online Sales VS Offline Sales 12.4.3 In - Vitro ADME Services Distributors 13 Market Dynamics 13.1 In - Vitro ADME Services Industry Trends 13.2 In - Vitro ADME Services Market Drivers 13.3 In - Vitro ADME Services Market Challenges 13.4 In - Vitro ADME Services Market Restraints 14 Research Findings and Conclusion 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（通信回線）の最新刊レポート
QYResearch社の医療分野での最新刊レポート
本レポートと同じKEY WORD（channel）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |
